Why Eli Lilly Stock Is Sinking Today | The Motley Fool

Oct 30, 2024 · Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More Why Eli Lilly …

CouponFollow Extension

30%
OFF

Why Eli Lilly Stock Tumbled On Thursday | The Motley Fool

2 days from now

Jan 18, 2024 · A healthcare stock that's been on quite a run so far this young year, Eli Lilly (LLY-1.30%) took a bit of a pause on Thursday. Its price sagged by nearly 1% on the day, in …

fool.com

3%
OFF

Why Eli Lilly Stock Is Sinking Today - The Globe And Mail

2 days from now

Why Eli Lilly Stock Is Sinking Today Motley Fool - Wed Oct 30, 10:34AM CDT Shares of Eli Lilly (NYSE: LLY) were sinking 6.3% lower as of 11:11 a.m. ET on Wednesday.

theglobeandmail.com

93%
OFF

Billionaire Ken Griffin Invested $93 Million Of ... - The Motley Fool

2 days from now

2 days ago · Semaglutide has been on the market since 2018, and it could soon be overtaken by Eli Lilly's (LLY 0.93%) tirzepatide. This is a next-generation treatment first approved in 2022. …

fool.com

26%
OFF

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

2 days from now

Nov 18, 2024 · Here's why they view Eli Lilly (LLY-0.26%), Novo Nordisk (NVO 2.37%), and Vertex Pharmaceuticals (VRTX 0.13%) as growth stocks you can buy right now without any …

fool.com

4%
OFF

Why Eli Lilly Stock Jumped By 4% Today - Nasdaq

2 days from now

May 6, 2024 · Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now…

nasdaq.com

5%
OFF

After It Drops 13.5% In A Day, Is It Time I Bought This S&P ... - Fool UK

2 days from now

Oct 30, 2024 · The Eli Lilly (NYSE:LLY) share price fell by double digits in the S&P 500 today, leaving this Fool debating whether he should reinvest. When investing, your capital is at risk. …

fool.co.uk

5%
OFF

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity

2 days from now

1 day ago · Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound. News. Today's news; US; Politics; …

yahoo.com

FAQs about Why Eli Lilly Stock Is Sinking Today | The Motley Fool Coupon?

What happened to Eli Lilly shares?

Shares of Eli Lilly (LLY 4.28%) were sinking 6.3% lower as of 11:11 a.m. ET on Wednesday. The sharp decline came after the big drugmaker announced its third-quarter results before the market opened. Lilly reported Q3 revenue of $11.4 billion, up 20% year over year. ...

Is Eli Lilly stock a buy?

With Eli Lilly's shares trading at a sky-high forward price-to-earnings ratio of 48, some investors might think this stock is too expensive to buy. My view, though, is that Lilly provides a textbook example of why forward earnings multiples don't always tell the full story. ...

Why is Lilly a bad stock?

Much of Lilly's recent dismal stock performance stems from its third-quarter update on Oct. 30. The company's Q3 revenue and earnings missed consensus Wall Street estimates. Lilly also significantly lowered its earnings guidance and the upper end of its revenue guidance range for the full year. That wasn't the only bad news for Lilly. ...

Should you buy Eli Lilly (LLY)?

Here's Why You Should Still Buy the Stock. Even a juggernaut like Eli Lilly (NYSE: LLY) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat, signaling that the market's reception to its financial performance was strongly negative. ...

Does Lilly stock have a sell-off?

However, since publishing a disappointing third-quarter earnings report a few weeks ago, Lilly stock has entered a free fall. Lilly stock is down 19% in just the last month, and has fallen by 8% just in the month of November. While it may be difficult to admit, a sell-off in Lilly stock is probably healthy at this point. ...

Is it a good time to buy Eli Lilly shares?

Eli Lilly is a leader in the GLP-1 market, but also has growing opportunities in Alzheimer's and eczema. Following a heavy sell-off over the last few weeks, now looks like a great time to buy some shares. Israel Englander of Millennium Management just pounced on one of the most lucrative opportunities in the pharmaceutical space. ...